Diabetes Medication Metformin Identified as Potential Key to Achieving Functional HIV Cure Through Viral Silencing

Gladstone Institutes researchers find metformin can activate genes that keep HIV dormant, potentially leading to a functional cure without daily meds.

By: AXL Media

Published: Mar 23, 2026, 5:38 AM EDT

Source: Information for this report was sourced from Gladstone Institutes

Decoding the Mechanics of Viral Latency

For the millions globally living with HIV, the necessity of a lifelong daily medication regimen remains a significant burden, as the virus typically resurfaces within weeks if treatment is paused. However, a landmark study has begun to unravel the biological secrets of "elite controllers"—rare individuals whose bodies naturally suppress the virus for months or years without drugs. By pinpointing the specific cellular features that keep the virus asleep, scientists have moved closer to a functional cure that focuses on permanent viral suppression rather than total elimination. This strategy aims to transition patients from a state of constant medication dependence to one of stable, drug-free remission.

The Discovery of Genetic Security Locks

The research team identified two specific genes, DDIT4 and ZNF254, which function as internal anchors within infected CD4+ T cells to prevent HIV from reactivating. Patients who naturally possessed higher levels of these genes demonstrated significantly longer periods of viral suppression after stopping traditional therapy. These genes represent the primary targets for the "block and lock" approach, a therapeutic concept where the virus is first obstructed from replicating and then epigenetically "locked" into a dormant state. Engineering stronger versions of these genes or delivering them directly to infected reservoir cells could potentially transform any patient into a natural suppressor of the virus.

Metformin as a Tool for Permanent Suppression

Perhaps the most immediate clinical ramification of the study is the role of metformin, a widely used and affordable diabetes medication. The researchers discovered that metformin can boost the levels of the DDIT4 gene within T cells, effectively silencing the latent HIV reservoir. In laboratory experiments, treating cells from HIV-positive individuals with metformin blocked the virus's ability to reactivate, suggesting the drug could be used to delay or even prevent viral rebound. Because metformin is already approved for human use and has a well-documented safety profile, it offers a highly accessible candidate for upcoming pre-clinical and clinical trials.